IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $198,000 | +88.6% | 20,707 | +277.0% | 0.01% | +75.0% |
Q4 2021 | $105,000 | +303.8% | 5,492 | +422.5% | 0.00% | +300.0% |
Q3 2021 | $26,000 | -97.6% | 1,051 | -97.4% | 0.00% | -97.1% |
Q2 2021 | $1,069,000 | +871.8% | 41,070 | +927.8% | 0.04% | +191.7% |
Q2 2020 | $110,000 | – | 3,996 | +14700.0% | 0.01% | – |
Q3 2019 | $0 | -100.0% | 27 | -95.6% | 0.00% | -100.0% |
Q2 2019 | $15,000 | -21.1% | 617 | -69.4% | 0.00% | -42.9% |
Q1 2019 | $19,000 | -44.1% | 2,019 | +1.2% | 0.01% | -61.1% |
Q1 2018 | $34,000 | – | 1,996 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |